The encoding gene was first implicated in CdLS when a de novo deletion that included BRD4 was identified in an individual with an atypical CdLS phenotype; targeted sequencing subsequently determined de novo intragenic variants in BRD4 (ref.18). This evidence concerns the gene BRD4 and Cornelia de Lange syndrome.